Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J BUON ; 14 Suppl 1: S69-78, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19785072

RESUMEN

Urothelial carcinoma of the bladder is the second most common genitourinary malignancy and the second most common cause of genitourinary cancer-related deaths with a worldwide estimate of about 300,000 new cases diagnosed every year. A significant problem in this type of cancer is the high recurrence rate of non-invasive primary tumors, leading to a high percentage of tumor progression and to a very poor 5-year survival rate. Targeted and gene therapy are currently the two major efforts in cancer treatment. Targeted therapy refers to strategies against specific cellular molecules deregulated in tumors, whereas gene therapy focuses on the genetic modification of tumor cells, mainly for correcting gene defects, inducing selective tumor cell death or modulating host's immune response. Recent advances in our understanding of the pathogenesis of bladder cancer at the molecular level have provided a significant number of cellular targets for therapy and have shown the importance of individualized therapy according to the molecular profile exhibited by the tumor cells. While the major problems of both targeted and gene therapy are far from being solved yet, both lines of cancer therapy hold promising results. This article aims at providing a brief general overview of this broad subject.


Asunto(s)
Técnicas de Transferencia de Gen , Terapia Genética/métodos , Neoplasias de la Vejiga Urinaria/genética , Neoplasias de la Vejiga Urinaria/terapia , Inhibidores de la Angiogénesis/uso terapéutico , Anticuerpos Monoclonales/uso terapéutico , Apoptosis/genética , Endostatinas/genética , Humanos , Complejo de la Endopetidasa Proteasomal/uso terapéutico , Receptor beta de Factor de Crecimiento Derivado de Plaquetas/antagonistas & inhibidores , Neoplasias de la Vejiga Urinaria/epidemiología , Factor A de Crecimiento Endotelial Vascular/fisiología
2.
Cell Motil Cytoskeleton ; 48(3): 224-33, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11223953

RESUMEN

In the present study, we demonstrate the actin cytoskeleton reorganization during nurse cells apoptosis of the olive fruit fly Dacus oleae. At the developmental stage 9A of oogenesis, the actin microfilaments are assembled in numerous ring canals and subcortically support all the nurse cells, as is shown by phalloidin-FITC staining. During the following stages, 9B and 10A, this structural pattern remains the same. The developmental stage 10B is characterized by actin microfilament rearrangement and formation of actin cables that are symmetrically organized around the nurse cell nuclei. At stage 11, when the dumping process begins, these actin cables seem to retain each nurse cell nucleus in the cell center, away from blocking the ring canals. The early stage 12 is characterized by an asynchronous nurse cell nuclear chromatin condensation, while at late stage 12 the actin cables become very thick, as adjacent ones overlap one another and traverse the disorganized apoptotic nurse cell nuclei that already have fragmented DNA, as is demonstrated by acridine orange staining and TUNEL assay. Finally, during stage 13, the apoptotic nuclear remnants are phagocytosed by the neighboring follicle cells. The data presented herein compared to previous reported results in Drosophila [Nezis et al., 2000: Eur J Cell Biol 79:610-620], demonstrate that actin cytoskeleton reorganization during nurse cell apoptosis is a developmentally regulated physiological mechanism, phylogenetically conserved in higher Dipteran.


Asunto(s)
Actinas/metabolismo , Actinas/fisiología , Apoptosis , Citoesqueleto/metabolismo , Dípteros/fisiología , Oogénesis/fisiología , Naranja de Acridina/farmacología , Animales , Núcleo Celular/metabolismo , Citoesqueleto/ultraestructura , Fragmentación del ADN , Colorantes Fluorescentes/farmacología , Etiquetado Corte-Fin in Situ , Microscopía Confocal , Microscopía Electrónica , Oocitos/metabolismo , Oocitos/ultraestructura , Fagocitosis , Faloidina/metabolismo , Factores de Tiempo
3.
Eur J Cell Biol ; 79(9): 610-20, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11043402

RESUMEN

In the present study we demonstrate the existence of two apoptotic patterns in Drosophila nurse cells during oogenesis. One is developmentally regulated and normally occurs at stage 12 and the other is stage-specific and is sporadically observed at stages 7 and 8 of abnormally developed follicles. The apoptotic manifestation of the first pattern begins at stage 11 and is marked by a perinuclear rearrangement of the actin cytoskeleton and the development of extensive lobes and engulfments of the nurse cell nuclei located proximal to the oocyte. Consequently, at late stage 12 (12C), half of the nurse cell nuclei exhibit condensed chromatin, while at late stage 13 all the nuclei have fragmented DNA, as it is clearly shown by TUNEL assay. Finally, the apoptotic vesicles that are formed during stage 13, are phagocytosed by the neighboring follicle cells and at stage 14 the nurse cell nuclear remnants can be easily detected within the adjacent follicle cell phagosomes. In the second sporadic apoptotic pattern, all the nurse cell nuclei are highly condensed with fragmented DNA, accompanied by a completely disorganized actin cytoskeleton. When we induced apoptosis in Drosophila follicles through an etoposide and staurosporine in vitro treatment, we observed a similar pattern of stage-specific cell death at stages 7 and 8. These observations suggest a possible protective mechanism throughout Drosophila oogenesis that results in apoptosis of abnormal, damaged or spontaneously mutated follicles before they reach maturity.


Asunto(s)
Apoptosis/fisiología , Drosophila melanogaster/citología , Oogénesis/fisiología , Folículo Ovárico/ultraestructura , Actinas/fisiología , Animales , Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Núcleo Celular/fisiología , Núcleo Celular/ultraestructura , Citoesqueleto/fisiología , Fragmentación del ADN , Drosophila melanogaster/crecimiento & desarrollo , Drosophila melanogaster/fisiología , Inhibidores Enzimáticos/farmacología , Etopósido/farmacología , Femenino , Etiquetado Corte-Fin in Situ , Microscopía Confocal , Microscopía Electrónica , Folículo Ovárico/fisiología , Fagocitosis/fisiología , Estaurosporina/farmacología
4.
J Mol Evol ; 48(5): 625-7, 1999 May.
Artículo en Inglés | MEDLINE | ID: mdl-10198128

RESUMEN

Protein-tyrosine dephosphorylation is a major mechanism in cellular regulation. A large number of protein-tyrosine phosphatases is known from Eukarya, and more recently bacterial homologues have also been identified. By employing conserved sequence patterns from both eukaryotic and bacterial protein-tyrosine phosphatases, we have identified three homologous sequences in two of the four complete archaeal genomes. Two hypothetical open reading frames in the genome of Methanococcus jannaschii (MJ0215 and MJECL20) and one in the genome of Pyrococcus horikoshii (PH1732) clearly bear all the conserved residues of this family. No homologues were found in the genomes of Archaeoglobus fulgidus and Methanobacterium thermoautotrophicum. This is the first report of protein-tyrosine phosphatase sequences in Archaea.


Asunto(s)
Archaea/enzimología , Archaea/genética , Proteínas Tirosina Fosfatasas/genética , Secuencia de Aminoácidos , Archaeoglobus fulgidus/enzimología , Archaeoglobus fulgidus/genética , Secuencia Conservada , Evolución Molecular , Genoma , Methanobacterium/enzimología , Methanobacterium/genética , Methanococcus/enzimología , Methanococcus/genética , Datos de Secuencia Molecular , Pyrococcus/enzimología , Pyrococcus/genética , Homología de Secuencia de Aminoácido
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...